ArticleCancer causes & control : CCC2026
Sleep duration and prostate cancer-specific mortality in the Southern Community Cohort Study.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeSleep patterns may affect metabolic and behavioral processes, which subsequently could be linked to cancer mortality. However, the relationship between sleep patterns and prostate cancer-specific mortality remains unclear. We evaluated the association of sleep and prostate cancer-specific mortality and investigated whether race/ethnicity influences the association.
methodsThe Southern Community Cohort Study (SCCS), a prospective cohort study, recruited participants from 12 Southeastern states between March 2002 and September 2009. The cohort included 34,166 males, predominantly Black/African American. Sleep exposures were measured via a baseline questionnaire. Cox Proportional hazards models were used to estimate associations between sleep and prostate cancer-specific mortality and were adjusted for important potential confounders.
resultsDuring follow-up (median 15.9 years), 225 men died from prostate cancer. Longer sleep duration (≥ 9 hours) on weekends versus 7-8 hours was suggestively associated with an increased risk of prostate cancer-specific mortality (hazard ratio (HR)= 1.44, 95% confidence interval (CI): 1.02-2.03). When stratified by race, longer sleep duration was suggestively associated with an increased risk of prostate cancer mortality for both Black and White men, although the associations were insignificant. Overall sleep duration and restless sleep were not associated with prostate cancer-specific mortality.
conclusionMen reporting ≥ 9 hours of weekend sleep had an elevated risk of prostate cancer-specific mortality compared with those sleeping 7-8 hours. Stratified analysis suggests an increased risk of prostate cancer-specific mortality among both Black men and White men with ≥ 9 hours of sleep versus 7-8 hours, though estimates were imprecise due to small event numbers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.